BG Medicine has announced the availability of galectin-3 testing services through Atherotech Diagnostics Lab. Atherotech leverages BGM Galectin-3 test to offer galectin-3 testing. The BGM Galectin-3 test was cleared as an aid in ...
Bristol-Myers Squibb, a biopharmaceutical company, has terminated the development of BMS-986094, an investigational NS5B nucleotide for the treatment of hepatitis C. Based on an ongoing assessment of patients in a Phase II study that the ...
Tags: BMS-986094, Bristol-Myers, hepatitis C, NS5B nucleotide
Theravance has entered into a research partnership with Merck, known as MSD outside the US and Canada, for the development of potential cardiovascular therapeutics to treat hypertension and heart failure. As per the agreement, Merck will ...
Tags: Cardiovascular Therapeutics, Theravance, Merck, MSD
Sagent Pharmaceuticals has introduced Acetazolamide for Injection, USP specified for adjunctive treatment of edema due to congestive heart failure, drug-induced edema, centrencephalic epilepsies and chronic simple glaucoma, secondary ...
Tags: Acetazolamide Injection, adjunctive treatment, Pharmaceuticals
The European Commission has cleared an oral anticoagulant, Eliquis, developed by Bristol-Myers Squibb (BMS) and Pfizer. Eliquis 5mg, trade name of apixaban in Europe, is indicated as a twice-daily drug for preventing strokes and systemic ...
Tags: BMS-Pfizer Oral Anticoagulant, oral anticoagulant, Eliquis, apixaban
Cytori Therapeutics has treated first US patient in the ATHENA trial using the company's cell therapy based on patient's own adipose-derived stem and regenerative cells (ADRCs). ADRCs are processed using the company's proprietary Celution ...
Sorin Group, a medical device company, has announced the approval and the commercial launch of the REPLY and ESPRIT families of pacemakers in China. The REPLY and ESPRIT families have common attributes such as smallest devices, ...
Tags: medical device, pacemakers, simplify medical device, REPLY pacemakers
CircuLite has obtained CE mark for its new micro-blood pump Synergy Circulatory Support system, designed to treat ambulatory heart failure patients (INTERMACS 4,5,6 / NYHA IIIB and early IV). The Synergy system, which is implanted ...
Cleveland Heart, a joint venture between Cleveland Clinic and TransWorld Medical Devices, has obtained $30m grant from Power Heart Consortium to develop its SmartHeart, continue international clinical trials, expand laboratory research and ...
Tags: clinic development, LVAD, investment
Daxor's BVA-100 blood volume analyzer has been purchased by a hospital located in Arizona ,US. Semi-automated BVA-100 analyzer is designed to provide rapid direct measurement of a patient's true blood volume. Daxor said the FDA-approved ...
Tags: Daxor Bva, blood volume analyzer, heart failure patients
Sunshine Heart has obtained conditional approval for its new C-Pulse system driver from the US Food and Drug Administration (FDA). The new driver, which features a lighter single unit and a number of software enhancements, is designed to ...
GlaxoSmithKline (GSK) will pay $3bn, which includes a $1bn criminal fine and forfeiture and $2bn to resolve civil claims, in fine and will plead guilty for promoting antidepressants Paxil and Wellbutrin for unapproved uses. The largest ...
Tags: antidepressant, criminal fine, civil claim, health care fraud
Gertrude Neumark Rothschild,whose research helped improve light-emitting and laser diodes now used in many cellphones,flat-screen televisions and Blu-ray disc players,and who waged a successful patent-infringement battle against some of the ...
Tags: Lights, LED, Lighting, Heart Failure